Shield Therapeutics plc (STX) Ordinary Shares 1.5p
0.30p
(2.04%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.30p
(2.04%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.30p
(2.04%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
15.25p
n/a
62.60p
£32.43 million
14.70p
n/a
14.50p
n/a
0.50p (3.29%) Previous:
0.50p
n/a
n/a
5,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2020 | 31/12/2019 |
|---|---|---|
| Revenue (£m) | 10.39 | 0.72 |
| Profit before tax (£m) | (1.89) | (9.07) |
| Adjusted EPS (p): | (1.94) | (7.77) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account.
Try our handy filter to explore the different options.
Ready to invest?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
Broker forecasts
Due to changes in how we source investment data, Broker Forecasts are not available. We're sorry for any inconvenience this may cause.
-
Shield's Canadian partner files new drug submission for Accrufer
21 March 2022 11:58
-
Shield Therapeutics revenue falls in line with expectations
17 February 2022 15:51
-
Shield Therapeutics enters Accrufer licensing deal in Canada
5 January 2022 13:43
-
Total Voting Rights Update
29 April 2022 07:00
-
Block Listing 6 Monthly Return
31 March 2022 15:50
-
Block Listing Application
31 March 2022 15:50
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Annual & interim reports
Annual & interim reports are not available for this stock.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.